Arcellx, Inc. (ACLX)
70.84
-3.24
(-4.37%)
USD |
NASDAQ |
Dec 09, 16:00
70.80
-0.04
(-0.06%)
After-Hours: 07:12
Arcellx EPS Diluted (Quarterly): -0.9858 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 2.434 |
| Geron Corp. | -0.0276 |
| Daré Bioscience, Inc. | -0.2793 |
| Cartesian Therapeutics, Inc. | -1.381 |
| Cabaletta Bio, Inc. | -0.4387 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -55.78M |
| Revenue (Quarterly) | 4.949M |
| Total Expenses (Quarterly) | 60.73M |
| Enterprise Value | 3.687B |
| Gross Profit Margin (Quarterly) | 62.76% |
| Profit Margin (Quarterly) | -1.13K% |
| Earnings Yield | -5.53% |
| Normalized Earnings Yield | -5.532 |